aap Implantate AG/€AAQ1
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About aap Implantate AG
aap Implantate AG is a medical technology company based in Berlin, Germany, specializing in the development, manufacturing, and marketing of trauma products for orthopedics. Its core offerings include the LOQTEQ® anatomical plating system and a range of cannulated screws designed for fracture treatment. The company is also advancing technologies such as antibacterial silver coating and magnesium-based implants to address unmet needs in trauma care. Founded in 1990, aap Implantate AG operates directly in Germany and through a network of distributors in approximately 25 countries, with a hybrid distribution strategy in the United States via its subsidiary, aap Implants Inc. In 2023, the company established a research and development and production headquarters in Suzhou New District, China, to conduct clinical trials on high-end silver ion anti-infection implants. This strategic expansion aims to enhance its presence in the Chinese market and leverage the region's favorable business environment.
Ticker
€AAQ1
Sector
Primary listing
XETRA
Industry
Health Care Equipment & Supplies
Headquarters
Employees
87
ISIN
DE000A3H2101
Website
AAQ1 Metrics
BasicAdvanced
€26M
-
-€0.28
-
-
Price and volume
Market cap
€26M
52-week high
€1.88
52-week low
€1.08
Financial strength
Current ratio
1.962
Quick ratio
0.888
Long term debt to equity
1.539
Total debt to equity
9.262
Interest coverage (TTM)
-5.31%
Profitability
EBITDA (TTM)
-0.855
Gross margin (TTM)
88.39%
Net profit margin (TTM)
-26.00%
Operating margin (TTM)
-19.46%
Effective tax rate (TTM)
-12.56%
Revenue per employee (TTM)
€160,000
Management effectiveness
Return on assets (TTM)
-9.62%
Return on equity (TTM)
-34.07%
Valuation
Price to revenue (TTM)
1.764
Price to book
2.83
Price to tangible book (TTM)
2.84
Price to free cash flow (TTM)
-16.941
Free cash flow yield (TTM)
-5.90%
Free cash flow per share (TTM)
-11.22%
Growth
Revenue change (TTM)
19.68%
Earnings per share change (TTM)
-54.68%
3-year revenue growth (CAGR)
4.32%
10-year revenue growth (CAGR)
-1.93%
3-year earnings per share growth (CAGR)
-18.28%
10-year earnings per share growth (CAGR)
6.53%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for aap Implantate AG stock?
aap Implantate AG (AAQ1) has a market cap of €26M as of July 04, 2025.
What is the P/E ratio for aap Implantate AG stock?
The price to earnings (P/E) ratio for aap Implantate AG (AAQ1) stock is 0 as of July 04, 2025.
Does aap Implantate AG stock pay dividends?
No, aap Implantate AG (AAQ1) stock does not pay dividends to its shareholders as of July 04, 2025.
When is the next aap Implantate AG dividend payment date?
aap Implantate AG (AAQ1) stock does not pay dividends to its shareholders.
What is the beta indicator for aap Implantate AG?
aap Implantate AG (AAQ1) does not currently have a Beta indicator.